Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

Authors :: Biagio Di Iorio
Domenico Russo
Donald A. Molony
Matteo Ruggeri
Antonio Bellasi
Filippo Cipriani
Cynthia S. Bell
Source :: Journal of Nephrology. 27:717-717
Publication Year :: 2014
Publisher :: Springer Science and Business Media LLC, 2014.

Subjects :: medicine.medical_specialty
business.industry
medicine.medical_treatment
Urology
medicine.disease
Sevelamer
First line treatment
chemistry.chemical_compound
Hyperphosphatemia
Calcium carbonate
chemistry
Nephrology
Economic evaluation
medicine
Hemodialysis
business
medicine.drug

Full Text Access

Tools